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Aims Aortic adaptive immunity plays a role in atherosclerosis; however, the precise mechanisms leading to T-cell activa-
tion in the arterial wall remain poorly understood.
....................................................................................................................................................................................................
Methods
and results
Here, we have identified naı¨ve T cells in the aorta of wild-type and T-cell receptor transgenic mice and we demon-
strate that naı¨ve T cells can be primed directly in the vessel wall with both kinetics and frequency of T-cell activa-
tion found to be similar to splenic and lymphoid T cells. Aortic homing of naı¨ve T cells is regulated at least in part
by the P-selectin glycosylated ligand-1 receptor. In experimental atherosclerosis the aorta supports CD4þ T-cell
activation selectively driving Th1 polarization. By contrast, secondary lymphoid organs display Treg expansion.
....................................................................................................................................................................................................
Conclusion Our results demonstrate that the aorta can support T-cell priming and that naı¨ve T cells traffic between the circula-
tion and vessel wall. These data underpin the paradigm that local priming of T cells specific for plaque antigens
contributes to atherosclerosis progression.
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1. Introduction
Aortic adaptive immune responses play a role in atherosclerosis,1 with
several immune cell subsets identified in human2,3 and murine4,5 vessels;
however, to date the precise mechanisms leading to T-cell activation in
the arterial wall remain poorly understood.
Several studies have investigated whether vascular resident antigen
presenting cells (APCs) retain the ability to present antigen locally to
T cells using reductionist approaches such as adoptive transfer of model
antigen loaded dendritic cells (DCs),6 in vitro co-culture systems,7 and
explanted aortas.8 Building on these approaches, antigen presentation
has been demonstrated in vivo by constitutive aortic plasmacytoid DCs
(pDCs).9,10 More recently, it was discovered that in the advanced stages
of atherosclerosis in apoE-/- mice, the vessel wall orchestrates the
formation of artery tertiary lymphoid organs that control vascular T-cell
responses with concomitant reduction in adjacent plaque size without
involvement of secondary lymphoid organs (SLOs).4 Therefore, current
evidence suggests that aortic APCs possess the capacity to present
antigen and that the aorta may act as a site of T-cell priming in
atherosclerosis.
In earlier stage pathology, it is assumed that adaptive immune
responses are co-ordinated in SLOs and/or the vessel wall, but naı¨ve
T cells have yet to be identified to reside constitutively in vascular tissue
and it remains controversial as to whether T-cell priming can occur
within the aorta. Therefore, in this investigation, we set out to address
the following questions: (i) Do naı¨ve CD4þ T cells reside in the aorta
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and by what mechanism are they recruited?; (ii) Can T-cell priming occur
directly in the aorta and where do T-cell/DC contacts take place?; and
(iii) How does the aortic CD4þ T-cell phenotype compare with T cells
in SLOs and are there divergent effects on these distinct populations af-
ter induction of pathology?
Our results demonstrate that the aorta can act as a site of naı¨ve
CD4þ T-cell priming and selectively induce a localized Th1 immune re-
sponse in early experimental atherosclerosis.
2. Methods
2.1 Animals
B6.129P2-Apoe(tm1Unc)/J (apoE-/-) mice, C57BL/6 (wild type; WT),
OT-II, and TEa mice were used in this study. All animals were euthanized
by carbon dioxide. No anaesthetic agent was used. For full details see
Supplementary material online. All the procedures were performed in
accordance with local ethical and UK Home Office regulations and con-
form to the guidelines from Directive 2010/63/EU of the European
Parliament on the protection of animals used for scientific purposes.
2.2 Flow cytometry
Cell suspensions from aortas were prepared by enzyme digestion as pre-
viously described.4,9 For experiments that involved removal of aortic ad-
ventitia, a modified digestion protocol was performed to allow removal
of adventitia.11 Spleens and renal lymph nodes (rLNs; abdominal aortic
draining) were digested in collagenase D (Sigma-Aldrich, Irvine, UK).
Intracellular staining was performed using a cytofix/cytoperm kit (BD
Biosciences, Oxford, UK) or a True-NuclearTM Transcription factor
buffer set (Biolegend, London, UK) according to the manufacturer’s
instructions. For BrdU staining, a BD Pharmigen FITC BrdU flow kit (BD
Biosciences) was used according to the manufacturer’s instructions.
Because T cells represent a major population (20%) of blood leuco-
cytes coupled with the fact that aortic naı¨ve T cells were likely to be
rare, we included an additional control for all T-cell experiments to en-
sure that T cells analysed were 100% aortic resident: 3 min prior to the
experiment endpoint, animals were injected i.v. with a CD45.1 antibody
(OT-II mice) or a CD45.2 antibody (WT, TEa, and apoE-/- mice) to label
circulating blood leucocytes for subsequent exclusion from analysis
(Supplementary material online, Figure S1B). Experiments were analysed
on a LSR II, LSRFortessa (BD Biosciences) or a MACSQuant Analyzer
(Miltenyi Biotec, Bisley, UK) using FlowJo (FlowJo LLC, Ashland, OR,
USA). For full details and antibodies used see Supplementary material
online.
2.3 Assessment of antigen-induced T-cell
proliferation in vivo
In one set of experiments, OT-II mice were injected i.v. with 200mg
chicken ovalbumin (OVA) and culled at 24, 48, or 72 h later. Phosphate-
buffered saline (PBS) served as naı¨ve control. Two hours prior to culling,
mice were injected with 1 mg BrdU i.p. Single cell suspensions were pre-
pared for aorta, rLNs, and spleen, and CD4þ OT-IIþ T cells stained for
proliferation markers: BrdU and Ki-67 as described in Supplementary
material online.
In a separate series of experiments, OT-II mice were injected with
1 mg/kg FTY720 (Sigma-Aldrich) and 2 mg/kg anti-P-selectin (RMP-1)
and anti-E-selectin (RME-1) antibodies (Biolegend) to block T-cell vascu-
lar recruitment, prior to receiving 200mg OVA. Treatment with FTY720
and anti-P-selectin/anti-E-selectin was repeated on Day 2 (24 h following
first dose) to maintain effective plasma concentrations. The control
group received 200mg OVA in addition to respective vehicle (dH2O)
and isotype control antibodies (mouse IgG1, k and mouse IgG2a, k).
Mice were culled 48 h following OVA administration (Supplementary
material online, Figure S2). Single cell suspensions of aorta, rLNs, and
spleen were obtained for flow cytometry analysis of CD4þOT-II prolif-
eration as assessed by Ki-67.
2.4 Blockade of aortic T-cell recruitment
WT mice were treated with 100mg anti-P-selectin glycosylated ligand
(PSGL-1; 4RA10) or equivalent dose of corresponding isotype (Bio X
Cell, West Lebanon, NH, USA) at 0 and 24 h to block aortic T-cell re-
cruitment. Mice were culled at 48 h after first dose. Aortic single cell sus-
pensions were obtained for flow cytometry quantification of total
CD45þ cells, CD4þ T cells, and naı¨ve CD4þ T cells.
2.5 Assessment of Th1 cytokine expression
WT and apoE-/- mice were injected i.p. with 300mg Brefeldin A (Sigma-
Aldrich) to block cytokine release and culled 5 h later. Aortas, spleens,
and rLNs were harvested and stained for intracellular cytokines via flow
cytometry as detailed in Supplementary material online.
2.6 Statistical analysis
Results are expressed as mean ± standard error of the mean (SEM)
of n animals/groups of pooled tissues for each experiment. The Student’s
t-test was used to compare two groups. Analysis of variance (ANOVA)
was used for comparing three or more groups with Tukey’s multiple
comparison post-test being applied as described in Figure legends.
GraphPad Prism 6 software (San Diego, CA, USA) was used. A P-value
<0.05 was taken to indicate statistical significance.
3. Results
3.1 Naı¨ve CD4þ T cells exist constitutively
in the adventitia and intima/medial layers
of WTaorta
The combination of perfusion and removal of extra-aortic tissue resulted
in a pure vascular preparation (Supplementary material online, Figure S1).
To determine the constitutive repertoire of T cells that reside in the
whole naı¨ve aorta, we employed high resolution cytometry by time of
flight (CyTOF) which revealed multiple distinct CD4þ and CD8þ T-cell
populations, two cd populations and unidentified T-cell subtypes
(Supplementary material online, Figure S3). Inspection of this data reveals
that the aorta harbours a mix of CD44low and CD44hi T cells
(Supplementary material online, Figure S3). Using flow cytometry, we
found40% of aortic CD4þ T cells expressed the classical naı¨ve pheno-
type: CD62LþCD44lo (Figure 1A). This compares with approximately
two-thirds of CD4þ T cells being naı¨ve in renal lymph nodes (rLNs),
spleen, and blood (Figure 1B–D). Further characterization demonstrated
that a clear CD4þ T-cell population could be observed both within the
adventitia and intima/media (Supplementary material online, Figure S4B).
Analysis of the T-cell population revealed naı¨ve CD4þ T cells in both
compartments but with a higher proportion of activated T cells
(CD44hi) being present within the adventitia (Supplementary material
online, Figure S4C). T cells were also visualized by confocal microscopy
and found to exist in both the intima and adventitia of the naı¨ve aorta
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..including T cells bound to the aortic endothelium (Supplementary
material online, Figure S7A). The presence of naı¨ve T cells within periph-
eral tissues remains a matter of controversy. To further validate our
finding that the aortic CD62LþCD44- cells are truly naı¨ve, we
employed TEa mice that consist of a CD4þ T-cell population expressing
a single T-cell receptor (TCR) specificity and are also RAG deficient,
thus T cells remain naı¨ve in the absence of Ea52–68: I-Ab complex (their
cognate antigen). By employing this model, we are able to determine if
naı¨ve T cells are capable of trafficking to and maintaining a clear resident
population within the aorta, even under non-inflammatory conditions.
This was indeed what we observed: In TEa mice, the vast majority of
CD4þ T cells in the aorta are CD62LþCD44-, conclusively demon-
strating that naı¨ve CD4þ T cells do indeed reside within the aorta
(Supplementary material online, Figure S5A). Data from renal lymph
nodes are presented for comparison where similarly, most CD4þ T cells
were CD62LþCD44- naı¨ve cells (Supplementary material online, Figure
S5B). The aorta, therefore, acts as a reservoir of naı¨ve CD4þ T cells that
may form interactions with aortic resident antigen presenting myeloid
cells. To fully delineate the repertoire of myeloid cells within the naı¨ve
aorta, we performed CyTOF analysis of C57BL/6 aortas which revealed
12 types of myeloid cells including multiple major histocompatibility
complex Class II (MHC-IIhi) populations consisting of distinct cDC and
macrophage subsets (Figure 2).
3.2 Priming of CD4þ T cells occurs within
the aorta
Evidence exists that T-cell activation occurs within the aorta,6,8,12 but
in vivo proof of naı¨ve T-cell priming is lacking. Conventional approaches of
assessing naı¨ve T-cell homing and antigen-dependent activation via adop-
tive transfer and subsequent priming in recipient mice is not feasible given
that recruitment of donor lymphocytes to the naı¨ve aorta make up only a
minor fraction of the total aortic lymphocyte population.6 Therefore, we
adopted the method of only investigating endogenous T-cell homing and
priming using OT-II mice. The use of OT-II mice, where the majority
of CD4þ T cells have a TCR specific for chicken ovalbumin (OVA) 323–
339 in the context of I-Ab (alloantigen of H-2b bearing mouse strains, in-
cluding mice on C57Bl/6 background), allows us to assess whether the
aorta can act as a site of priming by injecting OT-II mice with OVA so
that the great majority of aortic CD4þ T-cell-DC contacts will involve T
cells with a TCR specific for the OVA peptide presented by aortic cDCs.
PBS-treated OT-II aortas contained a similar proportion of naı¨ve CD4þ
T cells to WT mice (Figure 1E). Following administration of antigen, there
was a switch towards a more activated CD44hi phenotype with a con-
comitant reduction in naı¨ve T cells (Figure 1E). This was also true for
rLNs and spleen (Figure 1F and G) indicating each site harbours an
antigen-activated CD4þ population in parallel with a reduced frequency
CD62L
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Figure 1 Naı¨ve T cells constitutively reside in C57BL/6 wild-type aorta and are reduced in OT-II murine aorta following antigen administration. (A–D)
C57BL/6 wild-type mice were culled and single cell suspensions prepared for flow cytometry analysis of (A) aorta, (B) renal lymph nodes, (C) spleen, and (D)
blood. CD4þ T cells were stained with CD62L and CD44 to distinguish naı¨ve from activated cells. All plots are gated on CD4þTCR-bþ T cells. Results are
from two independent experiments, with each group containing five-pooled aortas. (E–G) In a separate experiment, OT-II mice were injected with ovalbu-
min or PBS and culled 72 h later. Single cell suspensions prepared for flow cytometry analysis of (E) aorta, (F) renal LNs, and (G) spleen were stained with
CD62L and CD44 to once again distinguish naı¨ve from activated cells. All plots are gated on CD4þVa2þVb5. Results are from two independent experi-
ments, with each group containing five-pooled aortas. Spleen, LNs, and blood were analysed individually.
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Figure 2 Mass cytometry reveals myeloid populations in C57BL/6 aorta. (A) Myeloid cells were gated as Lin-CD11blo-hi and clustered using viSNE on the
expression of cell surface and intracellular markers. Expression levels of selected myeloid markers in the resulting viSNE clustered cell populations is shown
for a representative C57BL/6 mouse. (B) Twelve cell populations consisting of monocytes (Ly6Cþ and Ly6C-), conventional Types 1 and 2 dendritic cells
(cDC1 and cDC2), neutrophils, five macrophage subsets, and two unidentified populations. Doughnut plot shows mean proportion of subsets in aortas
of n= 6 mice. (C) Heatmap showing the relative expression level of 20 cell markers within the 12 myeloid cell subsets identified by the viSNE clustering
shown in B.
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of naı¨ve T cells. Next, we sought to compare the kinetics of naı¨ve T-cell
activation in the aorta, rLNs, and spleen. To do this, we performed a
time-course experiment in OT-II mice injected with OVA using the pro-
liferation marker Ki-67. Additionally, we injected the animals with 1 mg
BrdU 2 h prior to culling to measure cells actively undergoing DNA syn-
thesis (S phase). A short BrdU pulse was employed to confine positive
detection to cells actively replicating locally in the tissue of interest and to
eliminate the contribution of cells that may have acquired BrdU in an-
other location and then migrated to the aorta. Following treatment with
OVA, the first Ki-67þ cells emerged at 24 h. All three compartments dis-
played broadly similar kinetics in terms of OT-II T-cell proliferation with
the aorta (Figure 3A) and spleen (Figure 3C) paralleling each other most
closely. The first BrdUþ cells become apparent in the aorta at 72 h, as
observed for the spleen and OT-IIþ T-cell proliferation (Ki-67þ cells)
was significantly greater at 72 h compared with untreated animals in all
three tissues analysed (Figure 3D–F). To summarize, we have shown the
existence of naı¨ve CD4þ T cells within WT, TEa, and OT-II murine aorta.
Moreover, the local vascular T-cell population becomes activated and
undergoes proliferation following systemic administration of a model
antigen.
To demonstrate aortic T-cell priming arises from a constitutive aortic
resident T-cell population, we set out to block T-cell recirculation and
blood derived T-cell binding/extravasation to the aorta utilizing FTY720
[functional antagonist on sphingosine 1-phosphate 1 (S1P1) receptors
causing internalization of S1P1 receptors on T cells which sequesters
lymphocytes in SLOs] to deplete the blood of T cells and blocking
antibodies to P-selectin and E-selectin (RMP-1 and RME-1, respectively).
FTY720 is highly efficient at sequestering T cells into SLOs and subse-
quently inducing lymphopenia in the blood.4,13,14 Leucocyte binding and
rolling on endothelium is critically dependent on P-selectin with a lesser
contribution from E-selectin,15–17 thus our rationale is that following this
treatment protocol followed by antigen challenge in OT-II mice
(Supplementary material online, Figure S2), we can confine T-cell priming
to aortic resident cells only. Firstly, to determine the effect of FTY720 (in
the presence of our blocking antibodies: RMP-1 and RME-1) on circulat-
ing blood CD4þ T cells, we treated mice over the course of 2 days
(FTY720þRMP-1/RME-1) at 0 and 24 h and quantified CD4þ T cells
at 48 h. This resulted in a 93% reduction in circulating CD4þ T cells
(Supplementary material online, Figure S6A). One factor that could con-
found interpretation of our results is that FTY720 can also deplete
T cells from peripheral tissues.18 Therefore, we assessed whether naı¨ve
T cells still reside in the aorta following FTY720þRMP-1/RME-1.
Following treatment, there was a reduction in aortic CD4þ T cells, likely
due to impaired trafficking. While the frequency of naı¨ve CD4þ T cells
was less than we had observed in untreated WT and OT-II mice previ-
ously, naı¨ve T cells still resided in the aorta at our experiment endpoint
(48 h) (Supplementary material online, Figure S6B) clearly indicating that
naı¨ve T cells would be available in the aorta for contact with OVA pep-
tide carrying APCs (contacts that occur within the first 24 h following an-
tigen). We studied 48 h as the earliest time point where a clear, distinct
population of proliferating OT-II T cells was observed within the aorta of
OT-II mice as shown in Figure 3A. As hypothesized, OT-II proliferation in
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Figure 3 Kinetics of antigen-dependent T-cell proliferation is similar in aorta compared to secondary lymphoid organs. OT-II mice were injected with
200mg OVA and culled at 24, 48, or 72 h later. PBS served as naı¨ve animal controls. Two hours prior to culling, mice were injected with 1 mg BrdU. Single
cell suspensions were prepared for aorta, renal LNs, and spleen, and CD4þOT-II T cells stained for proliferation markers: BrdU and Ki-67. Representative
plots for T-cell proliferation markers are shown for (A) aorta, (B) renal LNs, and (C) spleen. Frequency of proliferating CD4þ OT-II T cells are graphically
displayed for (D) aorta, (E) renal LNs, and (F) spleen. Results represent three independent experiments with aortas and renal LNs from three mice pooled
per group with spleens analysed individually. Individual data points represent average value per group/spleen; horizontal bars denote mean. Results are pre-
sented as mean ± SEM. One-way ANOVA followed by Tukey’s post hoc correction; *P< 0.05, **P< 0.01, ***P< 0.001 vs. PBS.
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.the treatment group was maintained at a level similar to the vehicle
group indicating that OT-II cells undergoing proliferation following OVA
were truly aortic resident (Figure 4).
To determine the location of DC-T-cell interactions within the aortic
wall, OT-II mice were treated with OVA or PBS and culled 20 h later in
order to visualize stable antigen-dependent contacts between DCs and
T cells (Supplementary material online, Figure S7). As noted above, T
cells resided in both the intima and adventitia and were sparsely scat-
tered as single cells throughout the aortic tree. As expected, DCs were
most notably located within the intima, lining the endothelium, and
within the subendothelial space. DCs were also located deep within the
media layer residing between smooth muscle fibres (Supplementary ma-
terial online, Figure S7B). Following administration of OVA, T cells, and
DCs showed co-localization with DC-T cells contacts observed in the
intima, adventitia and within the media (Supplementary material online,
Figure S7C). DC-T-cell contacts were not observed in PBS-treated mice.
In summary, these results clearly demonstrate that OT-II T cells are
being primed locally within the vessel wall.
3.3 Naı¨ve T-cell recruitment to the aorta is
suppressed by blockade of PSGL-1
Having identified naı¨ve T cells within the aorta, we investigated the
mechanism of naı¨ve T-cell homing from the circulation into aortic tissue.
PSGL-1 is the major leucocyte ligand for P-selectin, while also showing
affinity for E- and L-selectin19 but its role in vascular recruitment of naı¨ve
CD4þ T cells remains unknown. To investigate this, we injected C57BL/
6 WT mice with the anti-PSGL-1 antibody, 4RA10,20 on two consecutive
days and studied CD4þ T-cell populations within the aorta 48 h follow-
ing the first injection (Supplementary material online, Figure S8). Since
PSGL-1 is common to all leucocytes, there was a decrease in the number
of total leucocytes (>80%; 2.7-fold) in the vessel of anti-PSGL-1-treated
animals (Supplementary material online, Figure S8A). A marked reduction
was also identified for total CD4þ T cells (88%; 4.8-fold; Supplementary
material online, Figure S8B). Interestingly, both activated and naı¨ve T cells
were reduced by anti-PSGL-1 treatment with naı¨ve CD4þ T cells re-
duced by 96% which equated to a 5.7-fold reduction in this population
(Supplementary material online, Figure S8C). Our data demonstrate that
PSGL-1 has a key role in promoting naı¨ve T-cell recruitment to the aorta.
3.4 Early stage atherosclerosis is associated
with vascular T-cell expansion, activation
and selective Th1 polarization
Finally, we sought to assess differences in the phenotype of CD4þ
T cells in the aorta, rLNs, and spleen of WT vs. apoE-/- mice. As already
demonstrated by others,6 apoE-/- aortas contained significantly more
(400%) CD4þ T cells compared with WT (Figure 5A). In apoE-/- aortas,
we observed a lower frequency of naı¨ve CD4þ T cells and a significant
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Figure 4 T-cell proliferation following antigen is maintained in the aorta following blockade of lymphocyte trafficking and extravasation. OT-II mice were
injected with 1 mg/kg FTY720 (or vehicle) and 2 mg/kg anti-P-selectin and anti-E-selectin antibodies (or isotype) 2 and 1 h, respectively prior to received
200mg ovalbumin. Treatment with FTY720 and antibodies was repeated on Day 2 (24 h following first dose) to maintain effective plasma concentrations and
mice were culled 48 h following ovalbumin administration. Single cell suspensions of aorta, renal LNs, and spleen were obtained for flow cytometry analysis
of CD4þ OT-IIþ T-cell proliferation as assessed by Ki-67. Representative plots illustrating T-cell proliferation for (A) aorta, (B) renal LNs, and (C) spleen.
(D) Frequency of CD4þOT-IIþ T cells undergoing proliferation for each tissue. Results represent 3 independent experiments with 3–4 aortas and 3–4 sets
of renal lymph nodes pooled per group with spleens analysed individually (n= 11). Individual data points represent average value per group/spleen; horizon-
tal bars denote mean. Results are presented as mean ± SEM. The Student’s unpaired t-test; *P< 0.05.
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.switch from naı¨ve (CD62LþCD44-) to an effector memory (TEM)
population (CD62L-CD44þ) was noted (Figure 5B) concomitant with
increased surface expression of the T-cell activation marker CD69
(Figure 5C). No significant difference was noted for T-cell proliferation
(Figure 5D).
CD4þ tissue-resident memory cells (TRM) have been identified in
several tissues including lung21,22 and skin23 but have never been
investigated in the vasculature. Using a well-defined marker profile
for TRM, namely Sphingosine-1-phosphate receptor 1 (S1PR1)-
CD103þCD44þCD69þ, we identified a small population fitting the
TRM profile in the aortas of apoE
-/- mice and while the absolute number
of cells were low, they were 10 times higher than that observed in WT
aortas (Figure 5E).
On examination of rLNs and spleen (Figure 6), the CD4þ populations
were equivalent between WT and apoE-/- animals both for rLNs (Figure
6A) and spleen (Figure 6E). Both tissues showed a modest increase in
TEM cells (5%) in apoE-/- mice (Figure 6B and F, respectively) which is
in contrast to the 20% increase observed in apoE-/- aorta. Also, in
contrast to the aorta, no increase in CD44þCD69þ T cells was ob-
served in the rLNs (Figure 6C) or spleen (Figure 6G). The cells of rLNs in
apoE-/- mice did; however, show a higher rate of proliferation compared
with WT, a phenotype not observed in the spleen (Figure 6D and H,
respectively).
The major pro-atherosclerotic T-cell response in atherosclerosis is
driven by Th1 cells.24 We, therefore, employed direct in vivo intracellular
cytokine staining to quantify T cells actively secreting Th1 cytokines with-
out exogenous stimulation.25 Following 12 week’s high-fat diet (HFD),
mice were injected with Brefeldin A 5 h before culling. CD4þ T cells
were assessed for the expression of the signature Th1 cytokine: IFN-c in
addition to TNF-a (Figure 7A–C). There were 10 times more IFN-cþ
CD4þ T cells in apoE-/- aortas compared with WT. Aortic Th1 cells
were not actively producing TNF-a (Figure 7A). No significant differences
in the Th1 phenotype were observed in either rLNs or spleen (Figure 7B
and C, respectively).
We considered that the increased frequency of CD44hi CD4þ T cells
in the apoE-/- spleen and rLNs may be associated with Treg polarization
and expansion which is known to play a protective role in the pathol-
ogy.24 CD25þFoxP3þ Tregs were detected in both WT and apoE-/-
aortas and although a trend towards less Tregs was observed in apoE-/-
aortas, this did not reach significance (Figure 7D). This was in contrast to
SLOs where Tregs formed a larger proportion of the total CD4þ popu-
lation with this value increasing in apoE-/- rLNs (Figure 7E) and spleen
(Figure 7F). In summary, early stage atherosclerosis is associated with
vascular T-cell expansion, activation and selective Th1 polarization,
whereas SLOs are skewed towards enhanced Treg expansion as ob-
served previously.26
Figure 5 CD4þ T cells show a more activated phenotype in atherosclerotic aortas. Wild-type and apoE-/- mice were maintained on a high-fat diet for
10–12 weeks. Mice were culled and aortic single cell suspensions assessed via flow cytometry for (A) CD4þ T-cell number per vessel, (B) naı¨ve
(CD62LþCD44-) vs. effector memory (CD62L-CD44þ) T-cell phenotype, (C) activation status, and (D) proliferation. (E) Additionally, aortas were stained
for detection of TRM cells (S1PR1-CD103þCD44þCD69þ) cells. (A) Data shown represent n= 6–7 groups with each group comprising 3–8 pooled aortas
from 6 to 7 independent experiments. (B–E) Data shown represent n= 3–4 groups with each group comprising 6–8 pooled aortas from 3 to 4 independent
experiments. Individual data points represent average value per group; horizontal bars denote mean. Results are presented as mean ± SEM. The Student’s
unpaired t-test; *P< 0.05, **P< 0.01.
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..4. Discussion
We have conclusively identified naı¨ve T cells within the aorta of several
mouse strains. We also illustrated how the aorta supports local T-cell
priming in a model system. Indeed, in OT-II mice, aortic CD4þ T cells
can be primed as efficiently as lymphoid T cells. Naı¨ve T cells also de-
pend, at least in part, on PSGL-1 for aortic homing. We have also per-
formed a comparative assessment of the CD4þ T-cell phenotype
between the atherosclerotic aorta, an aortic draining lymph node and
the spleen, highlighting the importance of the local aortic immune re-
sponse. A significant Th1 response evolved in the aorta, whilst T cells in
SLOs were biased more towards a regulatory phenotype. These data
support the hypothesis that atherosclerosis induces local vascular Th1
cell responses and that this local response is quite distinct from the
more tolerogenic responses observed in SLOs.
Naı¨ve T cells have been identified in peripheral tissues including brain,
pancreas, lung, skin, and testes.27 Here, we demonstrate that naı¨ve
CD4þ T cells constitutively reside in the aorta of WT mice. We found
similar proportions of T cells amongst total leucocytes in both the ad-
ventitia and intima/media with naı¨ve T cells being detected in both com-
partments. We confirmed by microscopy that T cells can be found
bound to non-inflamed aortic endothelium and resided in close proxim-
ity to DCs indicating T cells may be able to enter the aortic wall from the
lumen. Indeed, microvessels are generally absent in the healthy aortic
wall,28 which strongly suggests that the major point of entry in naı¨ve
vessels is via the arterial lumen. The presence of naı¨ve T cells within the
intima/media is intriguing, given that the intima is the principal location of
APCs in the naı¨ve aorta7 where they accumulate in the subendothelial
space. Here, we have fully delineated the repertoire of myeloid cells
within the naı¨ve aorta by CyTOF analysis revealing 12 types of myeloid
cells including multiple MHC-IIhi APC populations. This offers the poten-
tial for naı¨ve T cells to encounter APCs in the environment where lipid
accumulation/oxidation and atherogenesis begins. Much of the evidence
regarding local T-cell activation and clonal expansion directly in the ves-
sel is circumstantial such as co-localization immunohistochemistry of ath-
erosclerotic plaques3 or the use of artificial systems ex vivo,8 hence it is
unknown if T-cell priming can occur in the aorta in vivo. We were able to
demonstrate activation of aortic OT-II T cells following antigen with ki-
netics paralleling those observed for splenic OT-II cells with peak prolif-
eration observed at 72 h. At 72 h, we also observed BrdU uptake,
indicating cells were undergoing mitosis. This was following a 2-h pulse
of BrdU, which would strongly indicate the BrdUþ cells were of a local
nature (i.e. in the target tissue of interest). To confirm this hypothesis,
we pre-treated OT-II mice with FTY720 and blocking antibodies to
P- and E-selectin prior to administration of antigen, thus ensuring any
clonally expanded OT-II T cells within the aorta could only derive from
endogenous naı¨ve T cells encountering an aortic APC presenting ovalbu-
min peptide on MHC-II. The result from this experiment confirmed that
priming of naı¨ve CD4þ cells occurred in the aortic wall and is direct evi-
dence that APCs within the vessel can uptake and present antigen locally
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Figure 6 CD4þ T-cell phenotype in renal lymph nodes and spleen of apoE-/- mice vs. wild-type. Wild-type and apoE-/- mice were maintained on a high
fat diet for 10–12 weeks. Mice were culled and single cell suspensions from (A–D) rLNs to (E–H) spleen were assessed via flow cytometry for (A, E) CD4þ
T-cell frequency, (B, F) naı¨ve vs. effector memory T-cell phenotype, (C, G) activation status, and (D, H) proliferation. Data shown represent n= 20–21 mice
from 3 to 4 independent experiments. Individual data points represent average value per mouse; horizontal bars denote mean. Results are presented as
mean ± SEM. The Student’s unpaired t-test; *P< 0.05, **P< 0.01, ***P< 0.001.
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..to CD4þ T cells and induce clonal expansion. Using OT-II mice, we
were able to visualize T cells and DCs forming cell contacts following an-
tigen challenge. Such contacts were observable in the adventitia, media,
and intima. Of interest, DCs and T cells were found to reside in areas of
the media where muscle fibres were less dense. The observation that
DCs and T cells can interact in all the aortic layers indicates that the ar-
chitecture of the aortic wall can support local T-cell activation, even
in the absence of a local inflammatory stimulus. Whilst priming of T
cells in healthy WT aorta is very unlikely given the small polyclonal
population that exists with respect of SLOs, the situation in athero-
sclerotic plaques may offer an environment more conducive to T-cell
activation. In the context of atherosclerosis—in the presence of
chronic pro-inflammatory stimuli—local antigen presentation could,
in theory, take place within the developing lesion, where T cells and
APCs are more highly concentrated with T cells co-localizing with ac-
tivated DCs.2,3 Evidence for aortic T-cell priming in atherosclerosis
was previously suggested in apoE-/- mice by the fact that the T-cell
repertoire within atherosclerotic aortas became more restricted
over the course of pathology while no changes in T-cell clonality
could be detected in SLOs.12
The mechanism by which naı¨ve T cells enter the aorta is unknown.
We identified PSGL-1, the major leucocyte ligand for endothelial selec-
tins, as a receptor of interest in regulating homing of naı¨ve T cells into
the aorta; since we demonstrated that naı¨ve T cells are depleted in the
aorta following anti-PSGL-1 treatment. PSGL-1 blockade or deficiency
reduced atherosclerosis formation, adhesive interactions between endo-
thelial cells and leucocytes, and neointima formation in apoE-/- mice.29–31
Naı¨ve T cells lack a fully glycosylated PSGL-1 so binding to selectins is
lower than for activated T cells yet some binding affinity still remains.32
Adoptively, transferred T cells have been previously shown to enter ath-
erosclerotic aortas in a partially L-selectin dependent manner despite L-
selectin receptors being absent from aortic tissue.6 This apparent dis-
crepancy can be reconciled by the fact that L-selectin expressed on an
endothelial bound T-cell binds to PSGL-1 on an unbound T-cell (a pro-
cess termed secondary capture).33 The initial interaction (primary cap-
ture) involves a T-cell binding to P- or E-selectin on the vessel wall. In
fact, it has been demonstrated that the absence of L-selectin has no ef-
fect on aortic leucocyte primary capture and rolling. Moreover, following
12 weeks HFD, neither T-cell number nor plaque area was altered be-
tween apoE-/- and apoE-/-/L-selectin-/- mice.34
We also noticed that TEM cells were less affected by PSGL-1 blockade
(2.7-fold reduction) compared with naı¨ve cells, making up a greater pro-
portion of the CD4þ cells in the treatment group compared with iso-
type. TEM cells may use additional receptors, to facilitate binding to
endothelial selectins including: T-cell immunoglobulin and mucin domain
1 (TIM-1),35 CD44,36 and E-selectin ligand-1.37 PSGL-1 on naı¨ve T cells
can also bind the chemokines, CCL19, and CCL2138 but expression of
these chemokines in vascular tissue is low or absent under non-
inflammatory conditions.4,39,40 Therefore, we consider these unlikely to
contribute to the reduced trafficking observed in WT mice. There may
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Figure 7 Atherosclerosis induces divergent effects on aortic vs. lymphoid tissue T-cell polarization. Wild-type and apoE-/- mice were maintained on a
high-fat diet for 10–12 weeks. Mice were then separated into two experimental groups. Group 1 received 300mg of Brefeldin A 5 h prior to culling and single
cell suspensions of (A) aorta, (B) rLNs, and (C) spleen were utilized for intracellular staining of CD4þ T cells for the Th1 cytokines: IFN-c and TNF-a.
Representative plots and graphs show IFN-cþ Th1 T cells. Plots are gated on CD4þTCR-b and results represent n= 3 per group with group containing
three pooled aortas, three pooled rLNs, and n= 8 spleens from three independent experiments. In Group 2, mice were culled and single cell suspensions of
(D) aorta, (E) rLNs, and (F) spleen were assessed via flow cytometry for the presence of CD4þ Tregs (CD25þFoxP3þ). Data shown for aorta represent
n= 3–4 groups with each group containing 6–8 pooled aortas. Data shown for rLNs and spleen represent n= 20–21 individual organs. All data derived from
3 to 4 independent experiments. Individual data points represent average value per group/organ; horizontal bars denote mean. Results are presented as
mean ± SEM. The Student’s unpaired t-test; *P< 0.05, **P< 0.01, ***P< 0.001.
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also be chemotactic factors in the vessel wall derived from myeloid cells
that contribute to the reduced trafficking of naı¨ve T cells observed after
PSGL-1 blockade, as an indirect effect, due to concurrent reductions in
other leucocyte subsets.
Finally, we performed a phenotypic analysis of CD4þ T cells between
WT and apoE-/- aortas, under similar HFD conditions. In line with previ-
ous results,6 here, we show that aortic CD4þ T cells display a near four-
fold increase in numbers in apoE-/- mice compared with WT mice. We
next investigated the relative proportions of naı¨ve vs. activated CD4þ T
cells. Naı¨ve CD4þ T cells were significantly reduced in aortas of apoE-/-
mice compared to WT, concomitant with an increase in TEM frequency.
In contrast, when we examined rLNs and spleens, we discovered that
the CD4þ populations were equivalent in terms of magnitude with only
a minor switch towards an activated phenotype, considerably less than
what was observed in the aorta. This is consistent with a lack of in-
creased proliferation of splenic CD4þ T cells previously observed at
8 weeks HFD in apoE-/- mice.41
Th1 cells are pro-atherosclerotic in both humans3,42,43 and animal
models.24 By employing intracellular cytokine staining to reveal in vivo cy-
tokine prolifes, we showed that IFN-cþ (Th1) T cells were 10 times
more abundant in apoE-/- aortas. In contrast, we did not detect significant
differences in the Th1 population in either the rLNs or spleen. We also
quantified CD4þ Tregs, which are known to be atheroprotective in ani-
mal models.24 Tregs were a small proportion of total CD4þ T cells
within the aorta with no significant differences between WT and apoE-/-
mice. In contrast, Tregs grew as a proportion of CD4þ T cells both in
rLNs and spleen. In support of this data, a study conducted on Foxp3-
eGFP/LDLr-/- mice showed a progressive increase in the frequency of
splenic CD4þ Tregs at 4, 8, and 20 weeks HFD, while the total CD4þ
T-cell population remained unchanged.26
The immune-mechanisms that drive aortic T-cell activation and Th1
response in apoE-/- mice are likely to be multi-factorial with both anti-
genic and non-antigenic stimuli contributing to the aortic resident T-cell
phenotype. One additional factor worth considering is the potential
presence of B cell follicles, resembling early tertiary lymphoid organs,
which can be found in even young apoE-/- mice44 and these structures, if
present, may exert immunomodulation on the underlying vascular T-cell
response.
We have used a model in vivo system to illustrate the capacity that the
naı¨ve aorta has to promote local T-cell priming. Other approaches that
could have further validated these findings such as orthotopic aortic
transposition utilizing an aortic graft from a donor with trackable (i.e.
fluorescent) cells could also have aided in discriminating local from sys-
temic immune effects. However, not only are such approaches techni-
cally challenging, the grafts would yield a very low number of T cells with
respect to an entire intact aorta thus necessitating a large number of sur-
geries to produce sufficient tissue for quantifiable data. Future studies,
however, utilizing such approaches coupled with detailed temporal phe-
notyping of TCR usage in experimental atherosclerosis would further
enhance our knowledge of when and where antigenic stimulation of T
cells occurs.
In conclusion, the aorta can support T-cell priming and local activation
of CD4þ T cells is associated with the vascular specific Th1 response we
observed in early stage atherosclerosis in the apoE-/- aorta.
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